SCHEMBL16147341

SCHEMBL16147341

CCCCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.56
ALDH1A1 P00352 3/20 0.56
AKR1B1 P15121 1/20 0.56
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 7/20 0.54
PPARD Q03181 7/20 0.54
PPARA Q07869 7/20 0.54
HDAC11 Q96DB2 5/20 0.54
PTPN1 P18031 3/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
KMT2A Q03164 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54
ALOX15 P16050 1/20 0.54
PDE4A P27815 1/20 0.54
PDE3A Q14432 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366608 1.00 TSHR (0.56) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL30519206 0.98 GPR84 (0.58) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL30519223 0.98 GPR84 (0.58) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL11700572 0.98 GPR84 (0.58) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL7570178 0.98 GPR84 (0.58) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL674092 0.98 TSHR (0.59) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL148702 0.96 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL8437709 0.96 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL6758778 0.96 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG
SCHEMBL2749487 0.96 GPR84 (0.60) TSHRALDH1A1AKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10344060-B2 Potent and selective inhibitors of Nav1.7 AMGEN INC. (US) 2019-07-09 US disclosed
US-20160024159-A1 POTENT AND SELECTIVE INHIBITORS OF NAV1.7 AMGEN INC. (US) 2016-01-28 US disclosed
EP-2970408-A2 POTENT AND SELECTIVE INHIBITORS OF Nav1.7 Amgen Inc. (US) 2016-01-20 EP disclosed
WO-2014165277-A2 POTENT AND SELECTIVE INHIBITORS OF Nav1.7 AMGEN INC. (US) 2014-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344060-B2 Potent and selective inhibitors of Nav1.7 SCN7A, SCN9A, SCN1A TSHR 4021/4885ALDH1A1 2149/4885AKR1B1 3465/4885
US-20160024159-A1 POTENT AND SELECTIVE INHIBITORS OF NAV1.7 SCN7A, SCN9A, SCN1A TSHR 4021/4885ALDH1A1 2149/4885AKR1B1 3465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.